Should I buy or sell Nature's Sunshine Products stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nature's Sunshine Products in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NATR shares. View NATR analyst ratings or view top-rated stocks .

What is Nature's Sunshine Products' stock price target for 2024?

1 Wall Street research analysts have issued 1 year target prices for Nature's Sunshine Products' stock. Their NATR share price targets range from $21.50 to $21.50. On average, they anticipate the company's stock price to reach $21.50 in the next year. This suggests a possible upside of 27.7% from the stock's current price. View analysts price targets for NATR or view top-rated stocks among Wall Street analysts .

How have NATR shares performed in 2023?

Nature's Sunshine Products' stock was trading at $8.32 at the beginning of the year. Since then, NATR shares have increased by 102.3% and is now trading at $16.83. View the best growth stocks for 2023 here .

When is Nature's Sunshine Products' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 20th 2024. View our NATR earnings forecast .

How were Nature's Sunshine Products' earnings last quarter?

Nature's Sunshine Products, Inc. (NASDAQ:NATR) released its earnings results on Tuesday, November, 7th. The company reported $0.15 earnings per share for the quarter. The company had revenue of $111.20 million for the quarter. Nature's Sunshine Products had a trailing twelve-month return on equity of 7.94% and a net margin of 1.84%.

What is Terrence Moorehead's approval rating as Nature's Sunshine Products' CEO?

13 employees have rated Nature's Sunshine Products Chief Executive Officer Terrence Moorehead on Glassdoor.com . Terrence Moorehead has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Nature's Sunshine Products own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nature's Sunshine Products investors own include Amicus Therapeutics (FOLD) , Gilead Sciences (GILD) , Pfizer (PFE) , AT&T (T) , AbbVie (ABBV) , Akorn (AKRX) , Bausch Health Companies (BHC) , Catalyst Pharmaceuticals (CPRX) , Exelixis (EXEL) and Global Blood Therapeutics (GBT) .

Who are Nature's Sunshine Products' major shareholders?

Nature's Sunshine Products' stock is owned by many different institutional and retail investors. Top institutional shareholders include Paradigm Capital Management Inc. NY (3.50%), Acadian Asset Management LLC (2.53%), Boston Partners (1.34%), Pacific Ridge Capital Partners LLC (1.20%), Tieton Capital Management LLC (0.53%) and Ancora Advisors LLC (0.52%). Insiders that own company stock include Bryant J Yates, Daniel C Norman, Nathan G Brower and Wynnefield Partners Small Cap. View institutional ownership trends .

How do I buy shares of Nature's Sunshine Products?

Shares of NATR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Nature's Sunshine Products Stock Price, News & Analysis (NASDAQ:NATR)

$16.83

-0.22 (-1.29%)

(As of 12/6/2023 ET)

Compare

Today's Range: $16.80
▼
$17.21
50-Day Range: $16.30
▼
$18.66
52-Week Range: $7.93
▼
$19.20

Volume: 59,619 shs
Average Volume: 49,913 shs
Market Capitalization: $321.12 million

P/E Ratio: 41.05
Dividend Yield: N/A
Price Target: $21.50

Nature's Sunshine Products MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 27.7% Upside
$21.50 Price Target
Short Interest: Healthy
0.31% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: Selling Shares
$104,403 Sold Last Quarter
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.40 out of 5 stars

Consumer Defensive Sector

4th out of 10 stocks

Packaged Foods Industry

1st out of 4 stocks

3.5

Analyst's Opinion

Consensus Rating
Nature's Sunshine Products has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $21.50, Nature's Sunshine Products has a forecasted upside of 27.7% from its current price of $16.83.
Amount of Analyst Coverage
Nature's Sunshine Products has only been the subject of 1 research reports in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
0.31% of the float of Nature's Sunshine Products has been sold short.
Short Interest Ratio / Days to Cover
Nature's Sunshine Products has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Nature's Sunshine Products has recently decreased by 11.37%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Nature's Sunshine Products does not currently pay a dividend.
Dividend Growth
Nature's Sunshine Products does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for NATR.

1.1

News and Social Media Coverage

News Sentiment
Nature's Sunshine Products has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.50 average news sentiment score of Consumer Defensive companies.
News Coverage This Week
MarketBeat has tracked 1 news article for Nature's Sunshine Products this week, compared to 1 article on an average week.
Search Interest
2 people have searched for NATR on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
MarketBeat Follows
Only 6 people have added Nature's Sunshine Products to their MarketBeat watchlist in the last 30 days. This is a decrease of -40% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Nature's Sunshine Products insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $104,403.00 in company stock.
Percentage Held by Insiders
Only 5.41% of the stock of Nature's Sunshine Products is held by insiders.
Percentage Held by Institutions
76.08% of the stock of Nature's Sunshine Products is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Nature's Sunshine Products is 41.05, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 120.14.
Price to Earnings Ratio vs. Sector
The P/E ratio of Nature's Sunshine Products is 41.05, which means that it is trading at a less expensive P/E ratio than the Consumer Defensive sector average P/E ratio of about 267.26.
Price to Book Value per Share Ratio
Nature's Sunshine Products has a P/B Ratio of 2.19. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Nature's Sunshine Products Stock (NASDAQ:NATR)

Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. The company was founded in 1972 and is headquartered in Lehi, Utah.

NATR Stock Price History

30 days | 90 days | 365 days | Advanced Chart

NATR Stock News Headlines

November 28, 2023 | americanbankingnews.com

Insider Selling: Nature's Sunshine Products, Inc. (NASDAQ:NATR) EVP Sells 3,999 Shares of Stock

November 27, 2023 | msn.com

Nature`s Sunshine Products (NATR) Price Target Increased by 10.26% to 21.93

December 7, 2023 | Financial Alphas (Ad)

Lithium Discovery So BIG You Can't Miss it, Even From Space

With the green energy transition well underway, lithium demand is rapidly outpacing projected supply. While companies frantically search for new sources of this critical metal, one small company is sitting on a massive claim in North America - So big in fact that it can clearly be seen from space!

November 23, 2023 | finance.yahoo.com

The Return Trends At Nature's Sunshine Products (NASDAQ:NATR) Look Promising

November 9, 2023 | finance.yahoo.com

Investing in Nature's Sunshine Products (NASDAQ:NATR) a year ago would have delivered you a 108% gain

November 8, 2023 | morningstar.com

Natures Sunshine Products Inc NATR

November 8, 2023 | finance.yahoo.com

Nature’s Sunshine Products, Inc. (NASDAQ:NATR) Q3 2023 Earnings Call Transcript

November 7, 2023 | finance.yahoo.com

Nature's Sunshine Reports Strong Third Quarter 2023 Results

December 7, 2023 | DTI Trader (Ad)

New CBOE “special perk” helps traders target income every weekend

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

October 24, 2023 | finance.yahoo.com

Nature’s Sunshine Sets Third Quarter 2023 Conference Call for Tuesday, November 7, 2023, at 5:00 p.m. ET

September 20, 2023 | finance.yahoo.com

Nature’s Sunshine Names Sarah Crockett Global Chief Marketing Officer

September 5, 2023 | msn.com

Nature's Sunshine Products: Revenue Growth Resumes

August 23, 2023 | finance.yahoo.com

Is Now The Time To Look At Buying Nature's Sunshine Products, Inc. (NASDAQ:NATR)?

August 18, 2023 | money.usnews.com

Nature`s Sunshine Products, Inc.

August 10, 2023 | msn.com

Nature's Sunshine GAAP EPS of $0.12, revenue of $116.5M

August 9, 2023 | finance.yahoo.com

Nature's Sunshine Reports Strong Second Quarter 2023 Results

August 9, 2023 | markets.businessinsider.com

Natures Sunshine Products earnings preview: what Wall Street is expecting

August 5, 2023 | msn.com

How I let the sunshine in after a skin cancer diagnosis

July 27, 2023 | finance.yahoo.com

Nature’s Sunshine Sets Second Quarter 2023 Conference Call for Wednesday, August 9, 2023, at 5:00 p.m. ET

July 3, 2023 | finance.yahoo.com

Owning 34% shares,institutional owners seem interested in Nature's Sunshine Products, Inc. (NASDAQ:NATR),

June 15, 2023 | finance.yahoo.com

Comparably Recognizes Nature’s Sunshine With Best Leadership Team Award 2023

June 2, 2023 | finance.yahoo.com

Nature's Sunshine Products (NASDAQ:NATR) shareholders have earned a 5.9% CAGR over the last five years

May 22, 2023 | finance.yahoo.com

Nature’s Sunshine Names Kevin Herbert as Executive Vice President & President of North America

May 17, 2023 | finance.yahoo.com

Has Nature's Sunshine Products, Inc.'s (NASDAQ:NATR) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

May 12, 2023 | msn.com

Natures Sunshine Products: Q1 Earnings Insights

May 11, 2023 | msn.com

DA Davidson Reiterates Nature`s Sunshine Products (NATR) Buy Recommendation

May 10, 2023 | finanznachrichten.de

Nature's Sunshine Products, Inc.: Nature's Sunshine Reports First Quarter 2023 Results

See More Headlines

Receive NATR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nature's Sunshine Products and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/07/2023
Today: 12/06/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 3/20/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Packaged Foods
Sub-Industry: Personal Products
Sector: Consumer Defensive
Current Symbol: NASDAQ:NATR
CUSIP: 63902710
CIK: 275053
Web: www.naturessunshine.com
Phone: (801) 341-7900
Fax: 801-342-4305
Employees: 800
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $21.50
High Stock Price Target: $21.50
Low Stock Price Target: $21.50
Potential Upside/Downside: +27.7%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.41
Trailing P/E Ratio: 41.05
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-390,000.00
Net Margins: 1.84%
Pretax Margin: 4.26%
Return on Equity: 7.94%
Return on Assets: 5.02%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 2.19
Quick Ratio: 1.28

Sales & Book Value

Annual Sales: $421.91 million
Price / Sales: 0.76
Cash Flow: $0.64 per share
Price / Cash Flow: 26.19
Book Value: $7.67 per share
Price / Book: 2.19

Miscellaneous

Outstanding Shares: 19,080,000
Free Float: 18,043,000
Market Cap: $321.12 million
Optionable: Not Optionable
Beta: 0.82

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

Mr. Terrence O. Moorehead (Age 60)
President, CEO & Director
Comp: $762.12k
Mr. L. Shane Jones (Age 52)
Executive VP, CFO & Treasurer
Mr. Martin Gonzalez (Age 54)
Executive Vice President of Global Supply Chain Operations
Comp: $546.38k
Trent McCausland
Executive Director, Head of Operations & COO
Mr. Nathan G. Brower (Age 43)
Executive VP, General Counsel & Secretary
Ms. Sarah Crockett
Global Chief Marketing Officer
Ms. Tracee Comstock (Age 57)
Vice President of Human Resources
Mr. Bryant J. Yates (Age 50)
Executive VP & President of Europe
Comp: $496.15k
Mr. Daniel C. Norman (Age 49)
Executive VP & President of Asia/Pacific (APAC)
Comp: $574.31k
Mr. Kevin R. Herbert
Executive VP & President of North America

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

NATR Stock Analysis - Frequently Asked Questions

Should I buy or sell Nature's Sunshine Products stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nature's Sunshine Products in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NATR shares.
View NATR analyst ratings or view top-rated stocks.
What is Nature's Sunshine Products' stock price target for 2024?: 1 Wall Street research analysts have issued 1 year target prices for Nature's Sunshine Products' stock. Their NATR share price targets range from $21.50 to $21.50. On average, they anticipate the company's stock price to reach $21.50 in the next year. This suggests a possible upside of 27.7% from the stock's current price.
View analysts price targets for NATR or view top-rated stocks among Wall Street analysts.
How have NATR shares performed in 2023?: Nature's Sunshine Products' stock was trading at $8.32 at the beginning of the year. Since then, NATR shares have increased by 102.3% and is now trading at $16.83.
View the best growth stocks for 2023 here.
When is Nature's Sunshine Products' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 20th 2024.
View our NATR earnings forecast.
How were Nature's Sunshine Products' earnings last quarter?: Nature's Sunshine Products, Inc. (NASDAQ:NATR) released its earnings results on Tuesday, November, 7th. The company reported $0.15 earnings per share for the quarter. The company had revenue of $111.20 million for the quarter. Nature's Sunshine Products had a trailing twelve-month return on equity of 7.94% and a net margin of 1.84%.

What is Terrence Moorehead's approval rating as Nature's Sunshine Products' CEO?: 13 employees have rated Nature's Sunshine Products Chief Executive Officer Terrence Moorehead on Glassdoor.com. Terrence Moorehead has an approval rating of 86% among the company's employees.
What other stocks do shareholders of Nature's Sunshine Products own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Nature's Sunshine Products investors own include Amicus Therapeutics (FOLD), Gilead Sciences (GILD), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Akorn (AKRX), Bausch Health Companies (BHC), Catalyst Pharmaceuticals (CPRX), Exelixis (EXEL) and Global Blood Therapeutics (GBT).
Who are Nature's Sunshine Products' major shareholders?: Nature's Sunshine Products' stock is owned by many different institutional and retail investors. Top institutional shareholders include Paradigm Capital Management Inc. NY (3.50%), Acadian Asset Management LLC (2.53%), Boston Partners (1.34%), Pacific Ridge Capital Partners LLC (1.20%), Tieton Capital Management LLC (0.53%) and Ancora Advisors LLC (0.52%). Insiders that own company stock include Bryant J Yates, Daniel C Norman, Nathan G Brower and Wynnefield Partners Small Cap.
View institutional ownership trends.
How do I buy shares of Nature's Sunshine Products?: Shares of NATR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:NATR) was last updated on 12/7/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial